Google+ Facebook Twitter Twitter

New targets for immunotherapy

Three separate studies have revealed potential new avenues for research into immunotherapy.

Two have highlighted molecules that may help cancer cells evade the immune system. 

While the other suggests that the effects of an experimental breast cancer drug could be boosted by immunotherapy.

In two studies researchers looked at one set of “brakes” – controlled by a checkpoint molecule called PD-L1 – which can prevent the immune system from launching an effective attack against cancer cells. 

They found that PD-L1 relies on two molecules called CMTM4 and CMTM6 to carry out its job in lab-grown cancer cells. 

These molecules made PD-L1 more stable, enhancing the ability of tumour cells to escape attack by certain immune cells. 

The third study looked at a targeted cancer drug that stops tumour cells growing. This drug was expected to stop tumours from getting any bigger, but lead researcher Dr Shom Goel said that some patients’ breast cancers also shrank following treatment in early clinical trials.

All three studies have been published in the journal Nature.

Related Articles

Preventing allergic reactions

Researchers have discovered a new mechanism in which an antibody can prevent allergic reactions in a broad range of patients.

No antibiotics for sore throats

Doctors should not prescribe antibiotics for most people with sore throats, say new guidelines. While most sore throats are caused by viral infections, research suggests antibiotics are prescribed in 60% of cases.

The enzyme that defines colon cancer

Researchers have identified an enzyme that is absent in healthy colon tissue but abundant in colon cancer cells. It appears to drive the conversion of normal tissue into cancer by attaching sugar molecules, or glycans, to proteins in the cell.

Repurposed Zika drug

A drug used to treat hepatitis C effectively protected and rescued neural cells infected by the Zika virus. The results were consistent across cell cultures and mouse models. It also blocked transmission of the virus to mouse foetuses, the research found.